key: cord-0690987-9lw8hcwj authors: Hasegawa, Gen; Sakai, Wataru; Chaki, Tomohiro; Tachibana, Shunsuke; Kokita, Atsushi; Kato, Takenori; Nishimura, Hidekazu; Yamakage, Michiaki title: Investigations into the efficacy of a novel extubation-aerosol shield: A cough model study date: 2021-12-04 journal: Infect Prev Pract DOI: 10.1016/j.infpip.2021.100193 sha: 5a0012e89f0f332171d43b7be0080f7de52a545f doc_id: 690987 cord_uid: 9lw8hcwj BACKGROUND: Physicians have had to perform numerous extubation procedures during the prolonged coronavirus disease 2019 (COVID 19) pandemic. Future pandemics caused by unknown pathogen may also present a risk of exposure to infectious droplets and aerosols. AIM: This study evaluated the ability of a newly developed aerosol barrier, “Extubation-Aerosol (EA)-Shield” to provide maximum protection from aerosol exposure during extubation via an aerosolised particle count and high-quality visualisation assessments. METHODS: We employed a cough model having parameters similar to humans and used micron oil aerosol as well as titanium dioxide as aerosol tracers. Aerosol barrier techniques employing a face mask (group M) and EA-Shield (group H) were compared. FINDINGS: The primary outcome was the difference in the number of particles contacting the physician’s face before and after extubation. The maximum distances of aerosol dispersal after extubation were measured as the secondary outcomes. All aerosolised particles of the two tracers were significantly smaller in group H than in group M (p < 0.05). In addition, the sagittal and axial maximum distances and sagittal areas of aerosol dispersal for 3, 5, and 10 s after extubation were significantly smaller in group H than in group M (p < 0.05). CONCLUSION: This model indicates that EA-Shield could be highly effective in reducing aerosol exposure during extubation. Therefore, we recommend using it as an aerosol barrier when an infectious aerosol risk is suspected. Physicians have had to perform numerous extubation procedures during the prolonged coronavirus disease 2019 (COVID 19) pandemic. Future pandemics caused by unknown pathogen may also present a risk of exposure to infectious droplets and aerosols. This study evaluated the ability of a newly developed aerosol barrier, "Extubation-Aerosol (EA)-Shield" to provide maximum protection from aerosol exposure during extubation via an aerosolised particle count and high-quality visualisation assessments. We employed a cough model having parameters similar to humans and used micron oil aerosol as well as titanium dioxide as aerosol tracers. Aerosol barrier techniques employing a face mask (group M) and EA-Shield (group H) were compared. The primary outcome was the difference in the number of particles contacting the physician's face before and after extubation. The maximum distances of aerosol dispersal after extubation were measured as the secondary outcomes. All aerosolised particles of the two tracers were significantly smaller in group H than in group M (p < 0.05). In addition, the sagittal and axial maximum distances and sagittal areas of aerosol dispersal for 3, 5, and 10 s after extubation were significantly smaller in group H than in group M (p < 0.05). This model indicates that EA-Shield could be highly effective in reducing aerosol exposure during extubation. Therefore, we recommend using it as an aerosol barrier when an infectious aerosol risk is suspected. J o u r n a l P r e -p r o o f INTRODUCTION Physicians must pay attention to droplet and aerosol exposure not only during intubation but also during extubation, which is a droplet and aerosol-generating procedure [1] . During a prolonged pandemic, such as that caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, physicians have to perform numerous extubation procedures that have a risk of infectious droplet and aerosol exposure. SARS-CoV-2 can be transmitted even by asymptomatic people through droplets and aerosols, and personal protective equipment (PPE) cannot completely protect against their spread [2, 3] . Anaesthetists and intensivists are at low risk of SARS-CoV-2 infection, possibly due to wellventilated working environment and the use of high-performance PPE [4] . However, in reality, aerosol procedures must be performed without sufficient air conditioning and PPE, when the distance between hospital beds is insufficient. Protection against viral infections during intubation, outside of a wellequipped environment has not yet been established. Pathogens including SARS-CoV-2, SARS-CoV, and influenza virus can be transmitted during aerosol-generating procedures [5] . Mass-producible and single-use aerosol barriers are needed during aerosol-generating procedures when there is a shortage of protective equipment. Several guidelines do not provide clear evidence of using aerosol barriers to protect against droplet infections during extubation [6] [7] [8] . Although several aerosol barriers have been developed for use, during these procedures [9] [10] [11] [12] [13] , they have not been fully tested to check the dispersal of aerosol particles of a size that would allow them to remain infectious. Although one guideline has recommended using a face mask as an aerosol barrier during extubation [14] , its effectiveness against aerosol protection is unclear. However, the dispersal of aerosols cannot be perceived visually by the naked eye. Protective methods need to be based on evidence of aerosol dispersal. Moreover, it is necessary to establish a safer method of extubation that can be performed under adverse conditions, including inadequate air conditioning and insufficient PPE. We have developed an aerosol barrier termed "Extubation-Aerosol (EA)-Shield" (Fig. 1) to protect physicians and medical staff against aerosol exposure during extubation. The barrier is mass-producible at a low cost and can be manufactured and used in developing countries. With the EA-Shield, emergency airway management after extubation, including mask ventilation and oral suctioning, can be performed without modification. This study assessed the ability of EA-Shield to provide effective protection against aerosol exposure during extubation that was performed using aerosolised particle counting and high-quality visualisation techniques. We used two types of light sources: white LED light (wavelength, 430-700 nm; 90 W) (Kato Koken) to assess the spatial aerosol spread and a thin green laser light sheet generated by a YVO4 laser (wavelength, 532 nm; 2,000 mW) (Kato Koken) to assess the sagittal and transverse aerosol spread from the mannequin's mouth and to measure the hydrodynamic outcomes. All coughing jet plume images were captured by a camera specialised for visualising fine particles (PV2, Kato Koken) with an optical resolution of 2,048 × 1,536 pixels per video frame. The maximum speed was 120 fps. All particle image velocimetry system images were captured using a high-speed camera (Kato Koken) with an optical resolution of 640 × 480 pixels per video frame. The maximum video frame speed was 8,000 fps. The white LED light was placed 2 m caudal to the mouth of the mannequin. Video cameras were placed on the side and 45 diagonally upwards. The green slit-sheet light and video camera were placed orthogonally. To prevent reflection of light that could lead to errors in the video graphic measurements, the physician dressed completely in black, and the mannequin was painted black by a professional painting company (Ihara Paint, Hokkaido, Japan). The image analysis was based on the principle that the intensity of the scattered light is proportional to the particle concentration. The area of scattered particles illuminated with the green slit-sheet light was recorded and analysed using image software Two different aerosol barrier techniques were used during extubation: i) Mask-over-tube extubation technique (face mask method: group M) [10] In this method, the tracheal tube was extubated while using the face mask to prevent aerosol dispersal caused by the patient's cough. This technique is recommended in published guidelines as an effective aerosol barrier method [14] . ii) Extubation with EA-Shield (Hasegawa method: Group H) The Hasegawa method requires only an EA-Shield. The details of the Hasegawa method are presented in Table SI . The primary outcome was the difference in the number of particles before and after extubation as aerosol exposure to the physician. The baseline values are listed in Table SII . In addition, the following secondary outcomes were verified using high-quality video images during extubation. i) Sagittal and axial distances of aerosol spread in videography taken from the mannequin's side with the green laser sheet for 3, 5, and 10 s after the air blower fired. ii) Sagittal area of aerosol spread in videography taken from in front of the mannequin with the green laser sheet, for 3, 5, and 10 s after the air blower fired. iii) Vectors of aerosol spread in videography were taken from the mannequin's side using a green laser sheet. Titanium dioxide was used as a tracer to measure secondary outcomes. The Shapiro-Wilk test was used to determine whether the data were normally distributed. Normally distributed variables are shown as the mean (SD), and non-normally distributed data are shown as median and interquartile range (IQR). Data were analysed using the unpaired t-test or Mann-Whitney U test. Statistical significance was set at p < 0.05. All statistical analyses for this study were performed using GraphPad Prism 8.0 (GraphPad Software, La Jolla, CA). Vector analysis was performed using software FlowExpert2D2C (Kato Koken, Isehara, Japan). According to our preliminary study of total particle counts, delta = 3,658,720 and SD = 1,946,610 represented significant differences (Table SIII) . Sample sizes were calculated using R. version 3.5.3, with α = 0.05, and 1-β = 0.8, revealing that five samples were required in each group. J o u r n a l P r e -p r o o f RESULTS All aerosolised particles of micron oil aerosol and titanium dioxide were significantly smaller in group H than in group M. The sizes of all aerosolised particles of both tracers in group H were within the baseline range. A summary of the primary outcomes is shown in Fig. 2 and Tables SIV and SV. Sagittal maximum distances of aerosol dispersal at 3, 5, and 10 s after the cough simulation were significantly smaller in group H than in group M. The axial maximum distances of aerosol dispersal for 3, 5, and 10 s after the cough simulation were also smaller in group H than in group M. The results of the sagittal and axial maximum distances of aerosol dispersal are presented in Table I . The sagittal maximum areas of aerosol dispersal for 3, 5, and 10 s after the cough simulation were significantly smaller in group H than in group M. All results for the area of aerosol dispersal in group H were within the baseline range. The results are presented in Table I An infection barrier must be cheap, mass-producible, and single-use. EA-Shield has all these characteristics because it can be made using a 120-l clear plastic bag and double-sided tape. Our experiment was performed even in a non-negative pressurised room, and the results revealed that EA-Shield could provide protection against aerosols in non-negative pressurised rooms, including patient wards, operating rooms, and intensive care units. By using the EA-Shield, emergency airway management after extubation, including mask ventilation and oral suctioning, can be performed without modification. In clinical practice, it can be adapted to the patient's body movements. Moreover, this shield was designed to allow effective ventilation inside using a fixed suction tube that creates a continuous negative pressure during the procedure (Video S1). After the patient's cough had subsided, he was made to wear a mask before the shield was removed. However, we believe that it is better to wear PPE because the Hasegawa method needs to be validated in clinical practice and has not been tested for exposure during discarding. Although particle counting can provide numerical and objective assessment, it provides fixed-point observations, because spatial assessment is not sufficient [15] [16] [17] . The volume aspirated during the measurement is small compared to space or ventilation, and particle counting is inevitably influenced by the direction of the inlet. Although visualisation assessments can easily determine the spatial and temporal dispersal of aerosols, it is difficult to obtain numerical and objective assessments from videography [18] [19] [20] . To provide a thorough evaluation of aerosol dispersal, we combined particle counting with these assessments. In addition, we used two types of tracers. Titanium dioxide particles have a wide range of diameters [21, 22] , whereas micron oil has good flowability for air movement [18] [19] [20] . The aerosol particles have a wide range of diameters (0.01-100 µm); therefore, it is difficult to assess the dispersal of these particles of all sizes, at once. Therefore, we measured the wind vector with micron oil, which has good tracking of air movement [23] [24] [25] . Measurement of the wind vector provided information regarding the dispersal of aerosol particles having small diameters (< 0.3 µm, which are invisible with a CCD camera) [26] . Particles 0.3 µm in diameter or larger could be assessed using titanium dioxide, particle counting, and visualisation assessments. Therefore, the combination of titanium dioxide and micron oil provides information regarding the dispersal of aerosol particles of all sizes. Our videography showed that EA-Shield could completely prevent aerosol exposure to the physician as well as in the surrounding area. It could protect the medical staff who stand by the patient as well as the instruments from aerosol exposure during extubation. We used two-dimensional and three-dimensional high-quality videography for visualisation assessments. Our results revealed that EA-Shield completely prevented aerosol dispersal. Although small particles (> 0.3 µm) can be detected using two-dimensional videography with the green slit-sheet light detects, spatial assessment is not sufficient because the laser-sheet light scatters only the particles on the laser line [18] [19] [20] . In addition, videography using a green slit-sheet laser has better quality than videography using other light sources because it is not easily affected by reflection. We used a green slit-sheet laser from two directions and assessed sagittal and axial aerosol dispersal. Measurement of the maximum distance and area of aerosol dispersal for 3, 5, and 10 s after cough simulation using green slit-sheet light could provide numerical and objective assessments [18] [19] [20] . This is the first study that assesses three-dimensional aerosol dispersal using white LED light. Threedimensional visualisation assessment using white LED light enables more detection of spatial and temporal aerosol dispersal than two-dimensional visualisation assessment. However, because white LED light is a wide-angle strong light source, reflection must occur, and numerical assessment may be difficult. The combination of two-dimensional and three-dimensional visualisation assessments can provide numerical, spatial, and temporal information on aerosol dispersal. According to the results obtained using a particle image velocimetry system, EA-Shield could prevent the generation of wind after extubation. It is therefore possible that EA-Shield can prevent transmission of aerosols and droplets as well as particles smaller than aerosols. A particle image velocimetry system has been used to assess aerosol dispersal from cough and cough parameters in several studies [23] [24] [25] . One study showed that the wind parameter determined by using a particle image velocimetry system enabled the assessment of the dispersal of aerosol particles with particles of small diameters [27] . The present results showed that using a face mask could not prevent exposure of the physician to aerosol particles, during extubation. Therefore, using this method could be a mistake. The Hasegawa method is highly reproducible and can be used by anyone. The results of the vector analysis revealed that this method accelerated the wind speed of the cough. This acceleration was caused by the narrow space between the face of the mannequin and the face mask compared to the mannequin's mouth, that could increase aerosol dispersal during extubation. Large aerosol particles (60-100 µm in diameter) have been found to be > 2 m with a velocity of 10 m/s recorded at the exit point [28] [29] . Using a face mask could generate dispersal of the aerosols at more than 10 m/s during extubation; therefore, the medical staff must maintain a distance of at least 2 m from the patient. In addition, an assistant is required for the physician during extubation; therefore, the face mask method increases the number of persons who could be exposed to aerosols, which does not obey the principle of aerosol protection. Moreover, the results obtained using the present particle image velocimetry system showed that the face mask method could generate turbulence. Turbulence is J o u r n a l P r e -p r o o f buoyant, increasing the aerosol dispersal and allowing the aerosolised particles to float in the air for a long time [30] . In contrast, the EA-Shield is an aerosol barrier that does not generate turbulence during extubation. Although we used two tracers in our experiment, the aerosol dispersal determined by our tracers would not be the same as the actual aerosol dispersal after extubation. In addition, in a clinical situation, the patient can move during extubation, and the direction of the cough and aerosol dispersal can be altered. Moreover, aerosol dispersal can be changed by environmental factors including atmospheric pressure, room wind, temperature, humidity, and room size, as well as by movement factors, including those of medical staff around the patient [31] [32] [33] [34] . We conducted our experiment with a trained physician in a quiet room. Therefore, clinicians must consider how they can utilise the present results to obtain individual protection from aerosol dispersal. EA-Shield, which can be crafted with common items, protects the physician against aerosol exposure during extubation. Therefore, we recommend using EA-Shield during extubation as an aerosol barrier when the risk of infectious aerosols is suspected. J o u r n a l P r e -p r o o f Sagittal and axial maximal distances and sagittal maximum areas 3, 5, and 10 s after the cough simulation and the maximum velocity of wind around the face of the mannequin were determined using a particle imaging velocimetry system. In group H, all sagittal and axial maximum distances were zero, but the maximum area in this group was not zero because some aerosolised particles were observed within the baseline range in the experimental room. The sagittal and axial maximum distances and sagittal maximum areas in group H were significantly smaller than those in group M. The axial maximum area could not be assessed because of the light reflection. In group H, wind was not observed around the face of the mannequin; therefore, maximum velocity could not be detected using the particle image velocimetry system. In group M, the wind speed around the face of the mannequin was higher than the cough speed (10 m/s) around the mouth of the mannequin because of the acceleration of wind speed in the space between the face mask and the face of the mannequin. A quantitative evaluation of aerosol generation during tracheal intubation and extubation COVID-19 transmission through asymptomatic carriers is a challenge to containment Personal protective equipment and COVID-19: a review for surgeons Occupational COVID-19 risk for anaesthesia and intensive care staff -low-risk specialties in a high-risk setting Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group Recommendations for endotracheal intubation of COVID-19 patients Particle sizes of infectious aerosols: implications for infection control Extubation of patients with COVID-19 Barrier enclosure during endotracheal intubation Safer intubation and extubation of patients with COVID-19 Cross-holes on a plastic bag can prevent droplet spread during extubation COVID-19 PICU guidelines: for high-and limited-resource settings Measurement of exposure during simulated tracheal intubation using various proposed aerosol containment devices during the COVID-19 pandemic Effectiveness of a negative-pressure patient isolation hood shown using particle count Aerosol retention characteristics of barrier devices Exhaled air dispersion during oxygen delivery via a simple oxygen mask Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks Noninvasive positivepressure ventilation: An experimental model to assess air and particle dispersion Characterization of aerosols of titanium dioxide nanoparticles following three generation methods using an optimized aerosolization system designed for experimental inhalation studies Generating nanoaerosols from TiO₂ (5 nm) nanoparticles showing different agglomeration states. Application to toxicological studies Characterization of expiration air jets and droplet size distributions immediately at the mouth opening Study on the initial velocity distribution of exhaled air from coughing and speaking Effectiveness of a personalized ventilation system in reducing personal exposure against directly released simulated cough droplets Peroral endoscopy during the COVID-19 pandemic: Efficacy of the acrylic box (Endo-Splash Protective (ESP) box) for preventing droplet transmission A new methodology for studying dynamics of aerosol particles in sneeze and cough using a digital high-vision, high-speed video system and vector analyses On air-borne infection: study II. Droplets and droplet nuclei How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve Violent respiratory events: on coughing and sneezing Modelling aerosol transport and virus exposure with numerical simulations in relation to SARS-CoV-2 transmission by inhalation indoors Effect of temperature, relative humidity and medium on the aerosol stability of infectious bovine rhinotracheitis virus Quantitative assessment of airborne exposures generated during common cleaning tasks: a pilot study We would like to thank Kouya Mikami of Kato Koken, Isehara, Japan, for their help with the experiments. Authors declare no conflict of interest. None.